Moreover, EphA3 has been shown to be over-expressed and functional on mesenchymal stromal cells in a number of human cancers, and EphA3 antibody targeting inhibited tumour growth by disrupting newly formed tumour microvasculature [13]. This evidence concerns the gene EPHA3 and cancer.